Editorial Commentary
A STEP ahead for CAR-T cell therapy of large B cell lymphoma: understanding the molecular determinants of resistance
Translational Cancer Research
2023;
12
(11)
:2970-2975
.
(30 November 2023)
Pregnancy wishes after breast cancer—an unsettled conflict solved?
Translational Cancer Research
2023;
12
(11)
:2976-2978
.
(30 November 2023)
HER destiny too
Translational Cancer Research
2023;
12
(11)
:2979-2983
.
(30 November 2023)
Interplay of homologous-recombination genes and Helicobacter pylori in gastric cancer susceptibility
Translational Cancer Research
2023;
12
(11)
:2984-2988
.
(30 November 2023)
Original Article
Comprehensive survival nomograms for locally advanced gastric cancer: a large population-based real-world study
Translational Cancer Research
2023;
12
(11)
:2989-3006
.
(30 November 2023)
Incidence trend and prognosis of intrahepatic cholangiocarcinoma: a study based on the SEER database
Translational Cancer Research
2023;
12
(11)
:3007-3015
.
(30 November 2023)
Role for ubiquitin-specific protease 7 (USP7) in the treatment and the immune response to hepatocellular carcinoma: potential mechanisms
Translational Cancer Research
2023;
12
(11)
:3016-3033
.
(30 November 2023)
Fruquintinib in combination with sintilimab or TAS-102 as third-line or above treatment in patients with metastatic colorectal cancer: a real-world study
Translational Cancer Research
2023;
12
(11)
:3034-3044
.
(30 November 2023)
Low OGDHL expression affects the prognosis and immune infiltration of kidney renal clear cell carcinoma
Translational Cancer Research
2023;
12
(11)
:3045-3060
.
(30 November 2023)
Development and validation of a nomogram for predicting the overall survival in non-small cell lung cancer patients with liver metastasis
Translational Cancer Research
2023;
12
(11)
:3061-3073
.
(30 November 2023)
Novel cuproptosis-related lncRNAs can predict the prognosis of patients with multiple myeloma
Translational Cancer Research
2023;
12
(11)
:3074-3087
.
(30 November 2023)
The stage-dependent prognostic role of ARID1A in hepatocellular carcinoma
Translational Cancer Research
2023;
12
(11)
:3088-3104
.
(30 November 2023)
New use of preoperative fibrinogen in ovarian cancer management
Translational Cancer Research
2023;
12
(11)
:3105-3112
.
(30 November 2023)
Proteomic analysis of small extracellular vesicles unique to cervical cancer
Translational Cancer Research
2023;
12
(11)
:3113-3128
.
(30 November 2023)
Glucocorticoid receptor regulates the epithelial-mesenchymal transition process through GR/ZEB1/E-cad and is involved in breast cancer endocrine drug resistance—a bioinformatics analysis
Translational Cancer Research
2023;
12
(11)
:3129-3146
.
(30 November 2023)
Risk factors predicting pathological degradation after cervical excision in cervical intraepithelial neoplasia grade II P16-positive patients over 25 years old: a cross-sectional study
Translational Cancer Research
2023;
12
(11)
:3147-3155
.
(30 November 2023)
LncRNA RP11-10E18.7 cooperates with lncRNA RP11-481C4.2 to affect the overall survival of breast cancer patients: a TCGA-based retrospective study
Translational Cancer Research
2023;
12
(11)
:3156-3165
.
(30 November 2023)
Review Article
Comparison of the diagnostic value of 18F-NaF PET/CT and 99mTc-MDP SPECT for bone metastases: a systematic review and meta-analysis
Translational Cancer Research
2023;
12
(11)
:3166-3178
.
(30 November 2023)
Therapeutic strategies for HER2-positive breast cancer with central nervous system involvement: a literature review and future perspectives
Translational Cancer Research
2023;
12
(11)
:3179-3197
.
(30 November 2023)
Research progress on the regulation and mechanism of borneol on the blood-brain barrier in pathological states: a narrative review focused on ischemic stroke and cerebral glioma
Translational Cancer Research
2023;
12
(11)
:3198-3209
.
(30 November 2023)
Case Report
Uterine intravascular leiomyomatosis involves the heart: a case report and literature review
Translational Cancer Research
2023;
12
(11)
:3210-3217
.
(30 November 2023)
Erratum
Erratum to survival outcomes of pancreaticoduodenectomy versus extended pancreaticoduodenectomy procedure for pancreatic head carcinoma: a propensity score matching study
Translational Cancer Research
2023;
12
(11)
:3218-3219
.
(30 November 2023)
Erratum to atorvastatin inhibits pancreatic cancer cells proliferation and invasion likely by suppressing neurotrophin receptor signaling
Translational Cancer Research
2023;
12
(11)
:3220-3221
.
(30 November 2023)
Retraction
Retraction: ET-1 promotes the growth and metastasis of esophageal squamous cell carcinoma via activating PI3K/Akt pathway
Translational Cancer Research
2023;
12
(11)
:3222
.
(30 November 2023)
